Adjusting Europe's drug regulation to public health needs

被引：44

作者：

Garattini, S ^{[1
]}

Bertele, V ^{[1
]}

机构：

[1] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy

来源：

关键词：

D O I：

10.1016/S0140-6736(00)05258-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：64 / 67

页数：4

共 12 条

[1] Inconclusive messages from equivalence trials in thrombolysis
Bertele, V
Torri, V
Garattini, S
[J]. HEART, 1999, 81 (06) : 675 - 676
[2] *EUR COMM, 1998, EUROPEAN COMMUNITI A, V2, P51
[3] *EUR COMM, 1998, EUROPEAN COMMUNITI A, V2, P15
[4] *EUR COMM, 1998, EUROPEAN COMMUNITI B, V2, P24
[5] *EUR FED PHARM IND, 2001, POINTS CONS SWITCH S
[6] European Commission, 1998, RES HUM RIGHTS VIOL, P1
[7] Multicentre clinical trials
Garattini, S
Bertele, V
[J]. LANCET, 1999, 353 (9156) : 930 - 930
[8] 1965, OFF J EUR COMM, P369
[9] 1989, OFF J EUR COMM, P8
[10] 1993, OFF J EUR COMM